Ir al contenido principal

growth differentiation factor 3

The GDF3 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF3 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. While the GDF3 protein is known to be involved in bone and cartilage development, its exact role is unclear.

Normal function

The GDF3 gene provides instructions for making a protein that is part of the transforming growth factor beta (TGFβ) superfamily, which is a group of proteins that help control the growth and development of tissues throughout the body. Within the TGFβ superfamily, the GDF3 protein belongs to the bone morphogenetic protein family, which helps regulate the growth and maturation (differentiation) of bone and cartilage. Cartilage is a tough but flexible tissue that makes up much of the skeleton during early development. The proteins in this family help regulate cell growth and differentiation both before and after birth. While the GDF3 protein is known to be involved in bone and cartilage development, its exact role is unclear.

The GDF3 protein is also involved in the development of the eyes, specifically the specialized light-sensitive tissue that lines the back of the eye called the retina.

Conditions referring to this gene or chromosome

Otros nombres

GDF-3

growth/differentiation factor 3

Related patient information and medicines

Cáncer de garganta

Patient information leaflet

Cáncer de garganta

(The throat is usually spr... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of siendo referred urgently by their GP for suspected cancer. To confirm the diagnosis If anything suspicious is seen by the.

Cáncer de pene

Patient information leaflet

Cáncer de pene

El exact reason why a cell becomes cancerous is un. It is thought that something damages or alters certain genes in the cell. By looking at certain features of the cells under the ... Grade 1 (low grade) - the cells look reasonably similar to normal cells. The cancer cells are said to be 'well differentiated'. Grade 2 - is a middle grade. Grade 3.

Retinopatía diabética

Patient information leaflet

Retinopatía diabética

New abnormal blood ... This is called proliferative retinopathy. These new vessels are delicate and can bleed easily. There are signs of blood flow becoming restricted but not yet showing new blood vessels growing (see below). Stage 3: proliferative retinopathy Proliferative retinopathy is the advanced diabetic retinopathy that occurs when damaged.

Cáncer de mama

Patient information leaflet

Cáncer de mama

Breast cancer is the most common cancer in women. ¿Qué es breast cancer? | Patient Explainers Breast cancer is the most common cancer in women. Find out more: [/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Follow Patient: Website: [/](https://patient.info/) Facebook:.

Acromegalia

Patient information leaflet

Acromegalia

Acromegalia is a rare, progressive condition in which you make too much growth hormone. This causes a range of symptoms that develop gradually, often over several years. The most noticeable symptoms are that your hands and feet become larger and features of your face may become more prominent. The cause is usually a small non-cancerous growth.

Presión arterial alta en el embarazo

Patient information leaflet

Presión arterial alta en el embarazo

Developing chronic hypertension in later life. The risks to your baby include: An increased chance of poor growth and a low birth weight. An increased chance of premature birth Premature labour. You may be offered a placental growth factor blood test to help rule out pre-eclampsia between 20 weeks y arriba a 35 weeks of pregnancy, if you are.

Historial del artículo

La información en esta página está escrita y revisada por pares por clínicos calificados.
  • 30 Sept 2025 | Última versión
  • 1 Sept 2025 | Publicado originalmente

Únete a la conversación

Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.

Aviso legal: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia en línea, tratamientos y servicios de salud

Acceso sencillo a tratamientos y servicios de salud confiables en línea.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Suscríbete al boletín de Patient

Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.

Por favor, introduce una dirección de correo electrónico válida

Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.